IB 
Union Calendar No. 596 
115TH CONGRESS 
2D SESSION 
H. R. 5925 
[Report No. 115–767, Part I] 
To codify provisions relating to the Office of National Drug Control, and 
for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
MAY 23, 2018 
Mr. GOWDY (for himself, Mr. CUMMINGS, Mr. MEADOWS, and Mr. CONNOLLY) 
introduced the following bill; which was referred to the Committee on 
Oversight and Government Reform, and in addition to the Committees 
on Energy and Commerce, Foreign Affairs, the Judiciary, Intelligence 
(Permanent Select), and Appropriations, for a period to be subsequently 
determined by the Speaker, in each case for consideration of such provi-
sions as fall within the jurisdiction of the committee concerned 
JUNE 20, 2018 
Reported from the Committee on Oversight and Government Reform with an 
amendment 
[Strike out all after the enacting clause and insert the part printed in italic] 
JUNE 20, 2018 
The Committees on Energy and Commerce, Foreign Affairs, the Judiciary, In-
telligence (Permanent Select), and Appropriations discharged; committed 
to the Committee of the Whole House on the State of the Unionand or-
dered to be printed 
[For text of introduced bill, see copy of bill as introduced on May 23, 2018] 
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6652
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
A BILL 
To codify provisions relating to the Office of National Drug 
Control, and for other purposes. 
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6652
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Coordinated Response 
through Interagency Strategy and Information Sharing 
Act’’ or the ‘‘CRISIS Act’’. 
SEC. 2. OFFICE OF NATIONAL DRUG CONTROL. 
(a) REDESIGNATION.—The Office of National Drug 
Control Policy shall be known as the ‘‘Office of National 
Drug Control’’. 
(b) REFERENCES.—Any reference in any other Federal 
law, Executive order, rule, regulation, or delegation of au-
thority, or any document of or relating to the Office of Na-
tional Drug Control Policy is deemed to refer to the Office 
of National Drug Control. 
(c) CODIFICATION.—Subtitle I of title 31, United 
States Code, is amended by adding at the end the following 
new chapter: 
‘‘CHAPTER 10—OFFICE OF NATIONAL 
DRUG CONTROL 
‘‘SUBCHAPTER I—OFFICE 
‘‘Sec. 
‘‘1001. Definitions. 
‘‘1002. Office of National Drug Control. 
‘‘1003. Administration of the office. 
‘‘1004. National drug control program budget. 
‘‘1005. National drug control strategy. 
‘‘1006. Development of an annual national drug control assessment. 
‘‘1007. Monitoring and evaluation of national drug control program. 
‘‘1008. Coordination and oversight of the national drug control program. 
‘‘1009. Emerging threats taskforce, plan, media campaign. 
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6213
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘1010. National and international coordination. 
‘‘1011. Interdiction. 
‘‘1012. Treatment coordinator. 
‘‘1013. Critical information coordination. 
‘‘1014. Annual audit and investigation requirements. 
‘‘1015. Authorization of appropriations. 
‘‘SUBCHAPTER II—HIGH INTENSITY DRUG TRAFFICKING AREAS PROGRAM 
‘‘1021. High intensity drug trafficking areas program. 
‘‘SUBCHAPTER III—DRUG-FREE COMMUNITIES SUPPORT PROGRAM 
‘‘1031. Establishment of drug-free communities support program. 
‘‘1032. Program authorization. 
‘‘1033. Information collection and dissemination with respect to grant recipients. 
‘‘1034. Technical assistance and training. 
‘‘1035. Supplemental grants for coalition mentoring activities. 
‘‘1036. Authorization for National Community Antidrug Coalition Institute. 
‘‘1037. Definitions. 
‘‘1038. Drug–free communities reauthorization. 
‘‘SUBCHAPTER I—OFFICE 
‘‘§ 1001. Definitions 
‘‘In this chapter: 
‘‘(1) AGENCY.—The term ‘agency’ has the mean-
ing given the term ‘executive agency’ in section 102. 
‘‘(2) APPROPRIATE
CONGRESSIONAL
COMMIT-
TEES.—The term ‘appropriate congressional commit-
tees’ means— 
‘‘(A) the Committee on the Judiciary, the 
Committee on Appropriations, and the Caucus 
on International Narcotics Control of the Senate; 
and 
‘‘(B) the Committee on Oversight and Gov-
ernment Reform, the Committee on the Judici-
ary, and the Committee on Appropriations of the 
House of Representatives. 
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(3) DEMAND REDUCTION.—The term ‘demand 
reduction’ means any activity conducted by a Na-
tional Drug Control Program Agency, other than an 
enforcement activity, that is intended to reduce or 
prevent the use of drugs or support or provide treat-
ment and recovery efforts, including— 
‘‘(A) education about the dangers of illicit 
drug use; 
‘‘(B) services, programs, or strategies to pre-
vent substance use disorder, including evidence- 
based education campaigns, community-based 
prevention programs, opioid diversion, collection 
and disposal of unused prescription drugs, and 
services to at-risk populations to prevent or 
delay initial use of an illicit substance; 
‘‘(C) substance use disorder treatment; 
‘‘(D) illicit drug use research; 
‘‘(E) drug-free workplace programs; 
‘‘(F) drug testing, including the testing of 
employees; 
‘‘(G) interventions for illicit drug use and 
dependence; 
‘‘(H) expanding availability of access to 
health care services for the treatment of substance 
use disorders; 
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(I) international drug control coordination 
and cooperation with respect to activities de-
scribed in this paragraph; 
‘‘(J) pre- and post-arrest criminal justice 
interventions such as diversion programs, drug 
courts, and the provision of evidence-based treat-
ment to individuals with substance use disorders 
who are arrested or under some form of criminal 
justice supervision, including medication assisted 
treatment; 
‘‘(K) other coordinated and joint initiatives 
among Federal, State, local, and Tribal agencies 
to promote comprehensive drug control strategies 
designed to reduce the demand for, and the avail-
ability of, illegal drugs; 
‘‘(L) international illicit drug use edu-
cation, prevention, treatment, recovery, research, 
rehabilitation activities, and interventions for il-
licit drug use and dependence; and 
‘‘(M) research related to any of the activi-
ties described in this paragraph. 
‘‘(4) DIRECTOR.—The term ‘Director’ means the 
Director of the Office of National Drug Control. 
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(5) DRUG.—The term ‘drug’ has the meaning 
given the term ‘controlled substance’ in section 102(6) 
of the Controlled Substances Act (21 U.S.C. 802(6)). 
‘‘(6) DRUG CONTROL.—The term ‘drug control’ 
means any activity conducted by a National Drug 
Control Program Agency involving supply reduction 
or demand reduction. 
‘‘(7) EMERGING THREAT.—The term ‘emerging 
threat’ means the occurrence of a new and growing 
trend in the use of an illicit drug or class of drugs, 
including rapid expansion in the supply of or de-
mand for such drug. 
‘‘(8) ILLICIT DRUG USE; ILLICIT DRUGS; ILLEGAL 
DRUGS.—The terms ‘illicit drug use’, ‘illicit drugs’, 
and ‘illegal drugs’ include the illegal or illicit use of 
prescription drugs. 
‘‘(9) LAW
ENFORCEMENT.—The term ‘law en-
forcement’ or ‘drug law enforcement’ means all efforts 
by a Federal, State, local, or Tribal government agen-
cy to enforce the drug laws of the United States or 
any State, including investigation, arrest, prosecu-
tion, and incarceration or other punishments or pen-
alties. 
‘‘(10) NATIONAL DRUG CONTROL PROGRAM.—The 
term ‘National Drug Control Program’ means pro-
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
grams, policies, and activities undertaken by Na-
tional Drug Control Program Agencies pursuant to 
the responsibilities of such agencies under the Na-
tional Drug Control Strategy, including any activi-
ties involving supply reduction, demand reduction, or 
State, local, and Tribal affairs. 
‘‘(11) NATIONAL DRUG CONTROL PROGRAM AGEN-
CY.—The term ‘National Drug Control Program 
Agency’ means any agency (or bureau, office, inde-
pendent agency, board, division, commission, subdivi-
sion, unit, or other component thereof) that is respon-
sible for implementing any aspect of the National 
Drug Control Strategy, including any agency that re-
ceives Federal funds to implement any aspect of the 
National Drug Control Strategy, but does not include 
any agency that receives funds for drug control activ-
ity solely under the National Intelligence Program or 
the Military Intelligence Program. 
‘‘(12) NATIONAL
DRUG
CONTROL
STRATEGY; 
STRATEGY.—The term ‘National Drug Control Strat-
egy’ or ‘Strategy’ means the strategy developed and 
submitted to Congress under section 1005. 
‘‘(13) NONPROFIT
ORGANIZATION.—The term 
‘nonprofit organization’ means an organization that 
is described in section 501(c)(3) of the Internal Rev-
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
enue Code of 1986 and exempt from tax under section 
501(a) of such Code. 
‘‘(14) OFFICE.—The term ‘Office’ means the Of-
fice of National Drug Control. 
‘‘(15) STATE, LOCAL, AND TRIBAL AFFAIRS.—The 
term ‘State, local, and Tribal affairs’ means domestic 
activities conducted by a National Drug Control Pro-
gram Agency that are intended to reduce the avail-
ability and use of illegal drugs, including— 
‘‘(A) coordination and enhancement of Fed-
eral, State, local, and Tribal law enforcement 
drug control efforts; 
‘‘(B) coordination and enhancement of ef-
forts among National Drug Control Program 
Agencies and State, local, and Tribal demand re-
duction and supply reduction agencies; 
‘‘(C) coordination and enhancement of Fed-
eral, State, local, and Tribal law enforcement 
initiatives to gather, analyze, and disseminate 
information and law enforcement intelligence re-
lating to drug control among domestic law en-
forcement agencies; and 
‘‘(D) other coordinated and joint initiatives 
among Federal, State, local, and Tribal agencies 
to promote comprehensive drug control strategies 
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
designed to reduce the demand for, and the avail-
ability of, illegal drugs. 
‘‘(16) SUBSTANCE USE DISORDER TREATMENT.— 
The term ‘substance use disorder treatment’ means an 
evidence-based, professionally directed, deliberate, and 
planned regimen including evaluation, observation, 
medical monitoring, and rehabilitative services and 
interventions such as pharmacotherapy, behavioral 
therapy, and individual and group counseling, on an 
inpatient or outpatient basis, to help patients with 
substance use disorder reach recovery. 
‘‘(17) SUPPLY
REDUCTION.—The term ‘supply 
reduction’ means any activity or program conducted 
by a National Drug Control Program Agency that is 
intended to reduce the availability or use of illegal 
drugs in the United States or abroad, including— 
‘‘(A) law enforcement outside the United 
States; 
‘‘(B) domestic law enforcement; 
‘‘(C) source country programs, including 
economic development programs primarily in-
tended to reduce the production or trafficking of 
illicit drugs; 
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(D) activities to control international traf-
ficking in, and availability of, illegal drugs, in-
cluding— 
‘‘(i) accurate assessment and moni-
toring of international drug production and 
interdiction programs and policies; and 
‘‘(ii) coordination and promotion of 
compliance with international treaties re-
lating to the production, transportation, or 
interdiction of illegal drugs; 
‘‘(E) activities to conduct and promote 
international law enforcement programs and 
policies to reduce the supply of drugs; 
‘‘(F) activities to facilitate and enhance the 
sharing of domestic and foreign intelligence in-
formation among National Drug Control Pro-
gram Agencies, relating to the production and 
trafficking of drugs in the United States and in 
foreign countries; 
‘‘(G) activities to prevent the diversion of 
drugs for their illicit use; and 
‘‘(H) research related to any of the activi-
ties described in this paragraph. 
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘§ 1002. Office of National Drug Control 
‘‘(a) ESTABLISHMENT OF OFFICE.—There is estab-
lished in the Executive Office of the President an Office of 
National Drug Control, which shall— 
‘‘(1) lead national drug control efforts, including 
developing and assessing implementation of evidence- 
based drug control policy; 
‘‘(2) coordinate and oversee the implementation 
of the national drug control policy, including the Na-
tional Drug Control Strategy; 
‘‘(3) assess and certify the adequacy of National 
Drug Control Programs and the budget for those pro-
grams; 
‘‘(4) monitor and evaluate the effectiveness of na-
tional drug control policy efforts, including the Na-
tional Drug Control Program Agencies’ programs, by 
developing and applying specific goals and perform-
ance measurements and tracking program-level spend-
ing; 
‘‘(5) identify and respond to emerging threats re-
lated to illicit drug use; 
‘‘(6) administer and evaluate grant programs in 
furtherance of the National Drug Control Strategy; 
and 
‘‘(7) facilitate broad-scale information sharing 
and data standardization among Federal, State, and 
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00012
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
local entities to support the national drug control ef-
forts. 
‘‘(b) DIRECTOR OF NATIONAL DRUG CONTROL AND 
DEPUTY DIRECTORS.— 
‘‘(1) DIRECTOR.— 
‘‘(A) IN GENERAL.—There shall be at the 
head of the Office a Director who shall hold the 
same rank and status as the head of an executive 
department listed in section 101 of title 5, 
United States Code. 
‘‘(B) APPOINTMENT.—The Director shall be 
appointed by the President, by and with the ad-
vice and consent of the Senate, and shall serve 
at the pleasure of the President. 
‘‘(2) DEPUTY DIRECTOR.— 
‘‘(A) IN GENERAL.—There shall be a Dep-
uty Director who shall report directly to the Di-
rector, be appointed by the President, and serve 
at the pleasure of the President. 
‘‘(B) RESPONSIBILITIES.—The Deputy Di-
rector shall— 
‘‘(i) carry out the responsibilities dele-
gated by the Director; and 
‘‘(ii) be responsible for effectively co-
ordinating with the Coordinators. 
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00013
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(c) RESPONSIBILITIES.— 
‘‘(1) POLICIES, GOALS, OBJECTIVES, AND PRIOR-
ITIES.—The Director shall assist the President in di-
recting national drug control efforts, including estab-
lishing policies, goals, objectives, and priorities for the 
National Drug Control Program that are based on 
evidence-based research. 
‘‘(2) CONSULTATION.—To formulate the National 
Drug Control policies, goals, objectives, and priorities, 
the Director— 
‘‘(A) shall consult with— 
‘‘(i) State and local governments; 
‘‘(ii) National Drug Control Program 
Agencies; 
‘‘(iii) each committee, working group, 
council, or other entity established under 
this chapter, as appropriate; 
‘‘(iv) the public; 
‘‘(v) appropriate congressional com-
mittees; and 
‘‘(vi) any other person in the discretion 
of the Director; and 
‘‘(B) may— 
‘‘(i) establish advisory councils; 
‘‘(ii) acquire data from agencies; and 
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00014
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(iii) request data from any other enti-
ty. 
‘‘§ 1003. Administration of the office 
‘‘(a) EMPLOYMENT.— 
‘‘(1) AUTHORITY OF THE DIRECTOR.—The Direc-
tor may select, appoint, employ, and fix compensa-
tion of such officers and employees of the Office as 
may be necessary to carry out the functions of the Of-
fice under this chapter. 
‘‘(2) PROHIBITIONS.— 
‘‘(A) GENERALLY.—No person shall serve as 
Director or Deputy Director while serving in 
any other position in the Federal Government. 
‘‘(B) PROHIBITION
ON
POLITICAL
CAM-
PAIGNING.—Any officer or employee of the Office 
who is appointed to that position by the Presi-
dent, by and with the advice and consent of the 
Senate, may not participate in Federal election 
campaign activities, except that such official is 
not prohibited by this paragraph from making 
contributions to individual candidates. 
‘‘(b) PROHIBITION ON THE USE OF FUNDS FOR POLIT-
ICAL CAMPAIGNS OR BALLOT INITIATIVES.—No funds au-
thorized under this chapter may be obligated for the purpose 
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00015
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
of influencing any Federal, State, or local election or ballot 
initiative. 
‘‘(c) PERSONNEL DETAILED TO OFFICE.— 
‘‘(1) EVALUATIONS.—Notwithstanding any pro-
vision of chapter 43 of title 5, the Director shall per-
form the evaluation of the performance of any em-
ployee detailed to the Office for purposes of the appli-
cable performance appraisal system established under 
such chapter for any rating period, or part thereof, 
that such employee is detailed to such office. 
‘‘(2) COMPENSATION.— 
‘‘(A) BONUS
PAYMENTS.—Subject to the 
availability of appropriations, the Director may 
provide periodic bonus payments to any em-
ployee detailed to the Office. 
‘‘(B) RESTRICTIONS.—An amount paid 
under this paragraph to an employee for any pe-
riod— 
‘‘(i) shall not be greater than 20 per-
cent of the basic pay paid or payable to 
such employee for such period; and 
‘‘(ii) shall be in addition to the basic 
pay of such employee. 
‘‘(C) AGGREGATE AMOUNT.—The aggregate 
amount paid during any fiscal year to an em-
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00016
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
ployee detailed to the Office as basic pay, 
awards, bonuses, and other compensation shall 
not exceed the annual rate payable at the end of 
such fiscal year for positions at level III of the 
Executive Schedule. 
‘‘(d) CONGRESSIONAL ACCESS TO INFORMATION.—The 
location of the Office in the Executive Office of the President 
shall not be construed as affecting access by Congress, or 
any committee of the House of Representatives or the Sen-
ate, to any— 
‘‘(1) information, document, or study in the pos-
session of, or conducted by or at the direction of the 
Director; or 
‘‘(2) personnel of the Office. 
‘‘(e) OTHER AUTHORITIES OF THE DIRECTOR.—In 
carrying out this chapter, the Director may— 
‘‘(1) use for administrative purposes, on a reim-
bursable basis, the available services, equipment, per-
sonnel, and facilities of Federal, State, and local 
agencies; 
‘‘(2) procure the services of experts and consult-
ants in accordance with section 3109 of title 5 relat-
ing to appointments in the Federal Service, at rates 
of compensation for individuals not to exceed the 
daily equivalent of the rate of pay payable under level 
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00017
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
IV of the Executive Schedule under section 5311 of 
such title; and 
‘‘(3) use the mails in the same manner as any 
other agency. 
‘‘(f) GENERAL SERVICES ADMINISTRATION.—The Ad-
ministrator of General Services shall provide to the Direc-
tor, on a reimbursable basis, such administrative support 
services as the Director may request. 
‘‘§ 1004. National drug control program budget 
‘‘(a) BUDGET RECOMMENDATIONS.—Not later than 
July 1 of each year, the Director shall provide to the head 
of each National Drug Control Program Agency budget rec-
ommendations, including requests for specific initiatives 
that are consistent with the priorities of the President under 
the National Drug Control Strategy, which shall— 
‘‘(1) apply to the budget for the next fiscal year 
scheduled for formulation under chapter 11, and each 
of the 4 subsequent fiscal years; and 
‘‘(2) address funding priorities developed in the 
National Drug Control Strategy. 
‘‘(b) RESPONSIBILITIES OF NATIONAL DRUG CONTROL 
PROGRAM AGENCIES.— 
‘‘(1) IN
GENERAL.—For each fiscal year, the 
head of each National Drug Control Program Agency 
shall transmit to the Director a copy of the proposed 
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00018
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
drug control budget request of such agency at the 
same time as that budget request is submitted to their 
superiors (and before submission to the Office of Man-
agement and Budget) in the preparation of the budget 
of the President submitted to Congress under section 
1105(a). 
‘‘(2) SUBMISSION
OF
DRUG
CONTROL
BUDGET 
REQUESTS.—The head of each National Drug Control 
Program Agency shall ensure timely development and 
submission to the Director of each proposed drug con-
trol budget request transmitted pursuant to this sub-
section, in such format as may be designated by the 
Director with the concurrence of the Director of the 
Office of Management and Budget. 
‘‘(3) CONTENT OF DRUG CONTROL BUDGET RE-
QUESTS.—A drug control budget request submitted by 
the head of a National Drug Control Program Agency 
under this subsection shall include all requests for 
funds for any drug control activity undertaken by 
such agency, including demand reduction, supply re-
duction, and State, local, and Tribal affairs, includ-
ing any drug law enforcement activities. If an activ-
ity has both drug control and nondrug control pur-
poses or applications, such agency shall estimate by 
a documented calculation the total funds requested for 
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00019
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
that activity that would be used for drug control, and 
shall set forth in its request the basis and method for 
making the estimate. 
‘‘(c) REVIEW AND CERTIFICATION OF BUDGET RE-
QUESTS AND BUDGET SUBMISSIONS OF NATIONAL DRUG 
CONTROL PROGRAM AGENCIES.— 
‘‘(1) IN
GENERAL.—The Director shall review 
each drug control budget request submitted to the Di-
rector under subsection (b). 
‘‘(2) REVIEW OF BUDGET REQUESTS.— 
‘‘(A) INADEQUATE REQUESTS.—If the Di-
rector concludes that a budget request submitted 
under subsection (b) is inadequate, in whole or 
in part, to implement the objectives of the Na-
tional Drug Control Strategy with respect to the 
agency or program at issue for the year for 
which the request is submitted, the Director shall 
submit to the head of the applicable National 
Drug Control Program Agency a written de-
scription identifying the funding levels and spe-
cific initiatives that would, in the determination 
of the Director, make the request adequate to im-
plement those objectives. 
‘‘(B) ADEQUATE REQUESTS.—If the Direc-
tor concludes that a budget request submitted 
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00020
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
under subsection (b) is adequate to implement 
the objectives of the National Drug Control 
Strategy with respect to the agency or program 
at issue for the year for which the request is sub-
mitted, the Director shall submit to the head of 
the applicable National Drug Control Program 
Agency a written statement confirming the ade-
quacy of the request. 
‘‘(C) RECORD.—The Director shall main-
tain a record of each description submitted 
under subparagraph (A) and each statement sub-
mitted under subparagraph (B). 
‘‘(3) SPECIFIC
REQUESTS.—The Director shall 
not confirm the adequacy of any budget request that 
requests a level of funding that will not enable 
achievement of the goals of the National Drug Control 
Strategy, including— 
‘‘(A) requests funding for Federal law en-
forcement activities that do not adequately com-
pensate for transfers of drug enforcement re-
sources and personnel to law enforcement and 
investigation activities; 
‘‘(B) requests funding for law enforcement 
activities on the borders of the United States that 
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00021
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
do not adequately direct resources to drug inter-
diction and enforcement; 
‘‘(C) requests funding for drug treatment 
activities that do not provide adequate results 
and accountability measures; 
‘‘(D) requests funding for drug treatment 
activities that do not adequately support and en-
hance Federal drug treatment programs and ca-
pacity; and 
‘‘(E) requests funding for the operations 
and management of the Department of Home-
land Security that does not include a specific re-
quest for funds for the Office of Counternarcotics 
Enforcement to carry out its responsibilities 
under section 878 of the Homeland Security Act 
of 2002 (6 U.S.C. 458). 
‘‘(4) AGENCY RESPONSE.— 
‘‘(A) IN GENERAL.—The head of a National 
Drug Control Program Agency that receives a 
description under paragraph (2)(A) shall include 
the funding levels and initiatives described by 
the Director in the budget submission for that 
agency to the Office of Management and Budget. 
‘‘(B) IMPACT STATEMENT.—The head of a 
National Drug Control Program Agency that has 
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00022
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
altered its budget submission under this para-
graph shall include as an appendix to the budget 
submission for that agency to the Office of Man-
agement and Budget an impact statement that 
summarizes— 
‘‘(i) the changes made to the budget 
under this paragraph; and 
‘‘(ii) the impact of those changes on the 
ability of that agency to perform its other 
responsibilities, including any impact on 
specific missions or programs of the agency. 
‘‘(C) CONGRESSIONAL
NOTIFICATION.—The 
head of a National Drug Control Program Agen-
cy shall submit a copy of any impact statement 
under subparagraph (B) to the Senate, the 
House of Representatives, and the appropriate 
congressional committees, at the time the budget 
for that agency is submitted to Congress under 
section 1105(a). 
‘‘(5) 
CERTIFICATION
OF
BUDGET
SUBMIS-
SIONS.— 
‘‘(A) IN GENERAL.—At the time a National 
Drug Control Program Agency submits its budg-
et request to the Office of Management and 
Budget, the head of the National Drug Control 
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00023
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
Program Agency shall submit a copy of the 
budget request to the Director. 
‘‘(B) REVIEW AND CERTIFICATION OF SUB-
MISSIONS.—The Director shall review each budg-
et submission submitted under subparagraph (A) 
and submit to the appropriate congressional 
committees one of the following: 
‘‘(i) A written certification of the budg-
et request for the agency indicating such re-
quest fully funds the National Drug Control 
Programs as necessary to achieve the goals 
of the National Drug Control Strategy, in-
cluding a written statement explaining the 
basis for the determination that the budget 
provides sufficient resources for the agency 
to achieve the goals of the Strategy. 
‘‘(ii) A written certification of the 
budget request for the agency indicating 
such request partially funds the National 
Drug Control Programs as necessary to 
achieve the goals of the Strategy, including 
a written statement explaining the basis for 
the determination and identifying the level 
of funding sufficient to achieve the goals of 
the Strategy. 
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00024
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(iii) A written decertification of the 
budget request for the agency indicating the 
Director is unable to determine whether 
such budget request for the agency fully 
funds or partially funds the National Drug 
Control Programs as necessary to achieve 
the goals of the National Drug Control 
Strategy, including a written statement 
identifying the additional information nec-
essary for the Director to make a deter-
mination on such budget and the level of 
funding sufficient to achieve the goals of the 
Strategy. 
‘‘(iv) A written decertification of the 
budget request for the agency indicating 
that such budget is insufficient to fund the 
National Drug Control Programs as nec-
essary to achieve the goals of the Strategy, 
including a written statement explaining 
the basis for the determination that the 
budget is insufficient and identifying the 
level of funding sufficient to achieve the 
goals of the Strategy. 
‘‘(d) NATIONAL DRUG CONTROL PROGRAM BUDGET 
PROPOSAL.—For each fiscal year, following the trans-
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00025
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
mission of proposed drug control budget requests to the Di-
rector under subsection (b), the Director shall, in consulta-
tion with the head of each National Drug Control Program 
Agency and the head of each major national organization 
that represents law enforcement officers, agencies, or asso-
ciations— 
‘‘(1) develop a consolidated National Drug Con-
trol Program budget proposal designed to implement 
the National Drug Control Strategy and to inform 
Congress and the public about the total amount pro-
posed to be spent on all supply reduction, demand re-
duction, State, local, and Tribal affairs, including 
any drug law enforcement, and other drug control ac-
tivities by the Federal Government, which shall con-
form to the content requirements set forth in sub-
section (b)(3) and include— 
‘‘(A) for each National Drug Control Pro-
gram Agency, a list of whether the funding level 
is full, partial, or insufficient to achieve the 
goals of the National Drug Control Strategy or 
whether the Director is unable to determine 
whether the budget request for the agency fully 
funds or partially funds the agency’s activities 
and contributions as necessary to achieve the 
goals of National Drug Control Strategy; 
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00026
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(B) a statement describing the extent to 
which any budget of a National Drug Control 
Program Agency with less than full funding 
hinders progress on achieving the goals of the 
National Drug Control Strategy; and 
‘‘(C) alternative funding structures that 
could improve progress on achieving the goals of 
the National Drug Control Strategy; and 
‘‘(2) submit the consolidated budget proposal to 
the President and Congress. 
‘‘(e) BUDGET ESTIMATE OR REQUEST SUBMISSION TO 
CONGRESS.—Whenever the Director submits any budget es-
timate or request to the President or the Office of Manage-
ment and Budget, the Director shall concurrently transmit 
copies of that estimate or request to the appropriate congres-
sional committees. 
‘‘(f) REPROGRAMMING AND TRANSFER REQUESTS.— 
‘‘(1) IN GENERAL.—No National Drug Control 
Program Agency shall submit to Congress a re-
programming or transfer request with respect to any 
amount of appropriated funds in an amount exceed-
ing $1,000,000 that is included in the National Drug 
Control Program budget unless the request has been 
approved by the Director. If the Director has not re-
sponded to a request for reprogramming subject to 
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00027
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
this paragraph within 30 days after receiving notice 
of the request having been made, the request shall be 
deemed approved by the Director under this para-
graph and forwarded to Congress. 
‘‘(2) APPEAL.—The head of any National Drug 
Control Program Agency may appeal to the President 
any disapproval by the Director of a reprogramming 
or transfer request under this subsection. 
‘‘§ 1005. National drug control strategy 
‘‘(a) IN GENERAL.— 
‘‘(1) STATEMENT
OF
DRUG
POLICY
PRIOR-
ITIES.—The Director shall release a statement of drug 
policy priorities in the calendar year of a Presi-
dential inauguration following the inauguration but 
not later than April 1. 
‘‘(2) NATIONAL DRUG CONTROL STRATEGY SUB-
MITTED BY THE PRESIDENT.—Not later than the first 
Monday in February following the year in which the 
term of the President commences, the President shall 
submit to Congress a National Drug Control Strat-
egy. 
‘‘(b) DEVELOPMENT OF THE NATIONAL DRUG CON-
TROL STRATEGY.— 
‘‘(1) PROMULGATION.—The Director shall pro-
mulgate the National Drug Control Strategy, which 
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00028
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
shall set forth a comprehensive plan to reduce illicit 
drug use and the consequences of such illicit drug use 
in the United States by limiting the availability of 
and reducing the demand for illegal drugs and pro-
moting prevention, early intervention, treatment, and 
recovery support for individuals with substance use 
disorders. 
‘‘(2) STATE AND LOCAL COMMITMENT.—The Di-
rector shall seek the support and commitment of 
State, local, and Tribal officials in the formulation 
and implementation of the National Drug Control 
Strategy. 
‘‘(3) STRATEGY BASED ON EVIDENCE.—The Di-
rector shall ensure the National Drug Control Strat-
egy is based on the best available medical and sci-
entific evidence regarding the policies that are most 
effective in reducing the demand for and supply of il-
legal drugs. 
‘‘(4) PROCESS FOR DEVELOPMENT AND SUBMIS-
SION OF NATIONAL DRUG CONTROL STRATEGY.—In 
developing and effectively implementing the National 
Drug Control Strategy, the Director— 
‘‘(A) shall consult with— 
‘‘(i) the heads of the National Drug 
Control Program Agencies; 
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00029
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(ii) the United States Interdiction 
Coordinator; 
‘‘(iii) the Interdiction Committee; 
‘‘(iv) the appropriate congressional 
committees and any other committee of ju-
risdiction; 
‘‘(v) State, local, and Tribal officials; 
‘‘(vi) private citizens and organiza-
tions, including community and faith-based 
organizations, with experience and expertise 
in demand reduction; 
‘‘(vii) private citizens and organiza-
tions with experience and expertise in sup-
ply reduction; and 
‘‘(viii) appropriate representatives of 
foreign governments; and 
‘‘(B) in satisfying the requirements of sub-
paragraph (A), shall ensure, to the maximum ex-
tent possible, that State, local, and Tribal offi-
cials and relevant private organizations commit 
to support and take steps to achieve the goals 
and objectives of the National Drug Control 
Strategy. 
‘‘(c) CONTENTS OF THE NATIONAL DRUG CONTROL 
STRATEGY.— 
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00030
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(1) IN GENERAL.—The National Drug Control 
Strategy submitted under subsection (a)(2) shall in-
clude the following: 
‘‘(A) A description of the current prevalence 
of illicit drug use in the United States, including 
both the availability of illicit drugs and the 
prevalence of substance use disorders, which shall 
include the following: 
‘‘(i) Such description for the previous 
three years for any drug identified as an 
emerging threat under section 1009 and 
any other illicit drug identified by the Di-
rector as having a significant impact on the 
prevalence of illicit drug use. 
‘‘(ii) A summary of the data and 
trends presented in the Drug Control Data 
Dashboard required under section 1013. 
‘‘(B) A mission statement detailing the 
major functions of the National Drug Control 
Program. 
‘‘(C) A list of comprehensive, research-based, 
long-range, quantifiable goals for reducing illicit 
drug use, including— 
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00031
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(i) the percentage of the total flow of 
illicit drugs to be interdicted during the 
time period covered by the Strategy; and 
‘‘(ii) the number of individuals to re-
ceive treatment for substance use disorders. 
‘‘(D) A description of how each goal listed 
in the National Drug Control Strategy will be 
achieved, including— 
‘‘(i) a list of relevant National Drug 
Control Program Agencies and each such 
agency’s related programs, activities, and 
available assets and the role of each such 
program, activity, and asset in achieving 
the goal; 
‘‘(ii) a list of relevant stakeholders and 
each such stakeholder’s role in achieving the 
goal; 
‘‘(iii) an estimate of Federal funding 
and other resources needed to achieve each 
goal; 
‘‘(iv) an identification of existing or 
new coordinating mechanisms needed to 
achieve the goal; and 
‘‘(v) a description of the Office’s role in 
facilitating the achievement of such goal. 
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00032
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(E) For each year covered by the Strategy, 
a performance evaluation plan for each goal list-
ed in the National Drug Control Strategy for 
each National Drug Control Program Agency, 
including— 
‘‘(i) specific performance measures for 
each National Drug Control Program Agen-
cy and each such agency’s related programs 
and activities; 
‘‘(ii) annual and quarterly objectives 
and targets for each performance measure; 
and 
‘‘(iii) an estimate of Federal funding 
and other resources needed to achieve each 
performance measure. 
‘‘(F) A list identifying existing data sources 
or a description of data collection needed to 
evaluate performance, including a description of 
how the Director will obtain such data. 
‘‘(G) A list of anticipated challenges to 
achieving the National Drug Control Strategy 
goals and planned actions to address such chal-
lenges; 
‘‘(H) A description of how each goal was de-
termined, including— 
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00033
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(i) a description of each required con-
sultation and how such consultation was in-
corporated; 
‘‘(ii) data, research, or other informa-
tion used to inform the decision; and 
‘‘(iii) a statement of whether the goal 
established in subparagraph (C)(i) will be 
adequate to disrupt drug trafficking organi-
zations that supply the majority of foreign- 
sourced illicit drugs trafficked into the 
United States. 
‘‘(I) A 5-year projection for program and 
budget priorities. 
‘‘(J) A review of international, State, local, 
and private sector drug control activities to en-
sure that the United States pursues coordinated 
and effective drug control at all levels of govern-
ment. 
‘‘(K) Such statistical data and information 
as the Director considers appropriate to dem-
onstrate and assess trends relating to illicit drug 
use, the effects and consequences of illicit drug 
use (including the effects on children), supply re-
duction, demand reduction, drug-related law en-
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00034
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
forcement, and the implementation of the Na-
tional Drug Control Strategy. 
‘‘(2) ADDITIONAL STRATEGIES.— 
‘‘(A) IN GENERAL.—The Director shall in-
clude in the National Drug Control Strategy the 
additional strategies required under this para-
graph and shall comply with the following: 
‘‘(i) Provide a copy of the additional 
strategies to the appropriate congressional 
committees and to the Committee on Armed 
Services and the Committee on Homeland 
Security of the House of Representatives, 
and the Committee on Homeland Security 
and Governmental Affairs and the Com-
mittee on Armed Services of the Senate. 
‘‘(ii) Issue the additional strategies in 
consultation with the head of each relevant 
National Drug Control Program Agency 
and any relevant official of a State, local or 
Tribal government, and the government of 
other countries. 
‘‘(iii) Not change any existing agency 
authority or construe any strategy described 
under this paragraph to amend or modify 
any law governing interagency relationship 
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00035
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
but may include recommendations about 
changes to such authority or law. 
‘‘(iv) Present separately from the rest 
of any strategy described under this para-
graph any information classified under cri-
teria established by an Executive order, or 
whose public disclosure, as determined by 
the Director or the head of any relevant Na-
tional Drug Control Program Agency, 
would be detrimental to the law enforcement 
or national security activities of any Fed-
eral, State, local, or Tribal agency. 
‘‘(B) REQUIREMENT FOR SOUTHWEST BOR-
DER COUNTERNARCOTICS.— 
‘‘(i) PURPOSES.—The Southwest Bor-
der Counternarcotics Strategy shall— 
‘‘(I) set forth the Government’s 
strategy for preventing the illegal traf-
ficking of drugs across the inter-
national border between the United 
States and Mexico, including through 
ports of entry and between ports of 
entry on that border; 
‘‘(II) state the specific roles and 
responsibilities of the relevant National 
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00036
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
Drug Control Program Agencies for 
implementing that strategy; and 
‘‘(III) identify the specific re-
sources required to enable the relevant 
National Drug Control Program Agen-
cies to implement that strategy. 
‘‘(ii) SPECIFIC CONTENT RELATED TO 
DRUG
TUNNELS
BETWEEN
THE
UNITED 
STATES AND MEXICO.—The Southwest Bor-
der Counternarcotics Strategy shall in-
clude— 
‘‘(I) a strategy to end the con-
struction and use of tunnels and sub-
terranean passages that cross the inter-
national border between the United 
States and Mexico for the purpose of il-
legal trafficking of drugs across such 
border; and 
‘‘(II) recommendations for crimi-
nal penalties for persons who construct 
or use such a tunnel or subterranean 
passage for such a purpose. 
‘‘(C) REQUIREMENT FOR NORTHERN BOR-
DER COUNTERNARCOTICS STRATEGY.— 
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00037
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(ii) information for the previous 10 
years regarding the number and type of sei-
zures of drugs by each National Drug Con-
trol Program Agency conducting drug inter-
diction activities and statistical informa-
tion on the geographic areas of such sei-
zures; and 
‘‘(iii) information for the previous 10 
years regarding the number of air and mar-
itime patrol hours undertaken by each Na-
tional Drug Control Program Agency con-
ducting drug interdiction activities and sta-
tistical information on the geographic areas 
in which such patrol hours took place. 
‘‘(D) CLASSIFIED ANNEX.—The report sub-
mitted pursuant to subparagraph (C) may in-
clude a classified annex. 
‘‘(b) INTERDICTION COMMITTEE.— 
‘‘(1) IN GENERAL.—The Interdiction Committee 
shall meet to— 
‘‘(A) discuss and resolve issues related to the 
coordination, oversight, and integration of inter-
national, border, and domestic drug interdiction 
efforts in support of the National Drug Control 
Strategy; 
VerDate Sep 11 2014 
20:53 Jun 20, 2018
Jkt 079200
PO 00000
Frm 00087
Fmt 6652
Sfmt 6203
E:\BILLS\H5925.RH
H5925
pbinns on DSK79D2C42PROD with BILLS